Evidence map›Paper›PMID 25090991›Full record

ReviewJournal of the American Society of Nephrology : JASN2015

New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.

Karim R Saab, Jessica Kendrick, Joseph M Yracheta, Miguel A Lanaspa, Maisha Pollard, Richard J Johnson

Open access · greenAbstract readReview
In one paragraph

Review in Journal of the American Society of Nephrology : JASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Karim R SaabRenal Division, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, Colorado;
Jessica KendrickRenal Division, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, Colorado;
Joseph M YrachetaDepartment of Pharmaceutics, University of Washington, School of Pharmacy, Seattle, Washington;
Miguel A LanaspaRenal Division, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, Colorado; Colorado Research Partners LLC, Aurora, Colorado; and.
Maisha PollardFields Foundation, Aurora, Colorado.
Richard J JohnsonRenal Division, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, Colorado; Colorado Research Partners LLC, Aurora, Colorado; and Richard.johnson@ucdenver.edu.
University of Colorado Anschutz Medical Campus · USUniversity of Washington · US

Funding

Vitamin D and Arterial Function in Patients with Chronic Kidney DiseaseK23DK087859 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI KENDRICK, JESSICA B · 2011 to 2015
$784k
NIDDK NIH HHS K23 DK087859
6 · The paper itself

Abstract

African Americans are at increased risk for cardiovascular and metabolic diseases, including obesity, high BP, diabetes, CKD, myocardial infarction, and stroke. Here we summarize the current risks and provide an overview of the underlying risk factors that may account for these associations. By reviewing the relationship between cardiovascular and renal diseases and the African-American population during the early 20th century, the historic and recent associations of African heritage with cardiovascular disease, and modern population genetics, it is possible to assemble strong hypotheses for the primary underlying mechanisms driving the increased frequency of disease in African Americans. Our studies suggest that underlying genetic mechanisms may be responsible for the increased frequency of high BP and kidney disease in African Americans, with particular emphasis on the role of APOL1 polymorphisms in causing kidney disease. In contrast, the Western diet, particularly the relatively high intake of fructose-containing sugars and sweetened beverages, appears to be the dominant force driving the increased risk of diabetes, obesity, and downstream complications. Given that intake of added sugars is a remediable risk factor, we recommend clinical trials to examine the reduction of sweetened beverages as a primary means for reducing cardiovascular risk in African Americans.

Indexed as

Apolipoprotein L1ApolipoproteinsBlack or African AmericanCardiovascular DiseasesDietary SucroseHumansHypertensionKidney DiseasesLipoproteins, HDLObesityPrevalenceRisk FactorsAPOL1 protein, humanApolipoprotein L1ApolipoproteinsDietary SucroseLipoproteins, HDLchronic kidney diseaseEthnic minorityhypertension

Identifiers

PMID25090991
PMCPMC4310665
OpenAlexW2169573881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.